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The role of a panel of pro-fibrogenic miRs in fibrotic lung disorders. 
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Rationale Pulmonary idiopathic fibrosis (IPF), Cryptogenetic organizing pneumonia (COP) and 
bronchiolitis obliterans syndrome (BOS) are rare pulmonary disorders, linked by the presence of 
fibrotic lesions. In our previous work (Di Carlo, 2016) on BOS we computationally identified a panel 
of candidate miRNAs and demonstrated by in situ hybridization analysis (ISH) and qRT-PCR, a 
dysregulation of two highly ranked miRNAs, miR-21 and miR-34a;ISH confirmed abnormal miR-21 
and miR-34a expression in BOS lesions; other miRNAs where indicated as potential candidates in 
BOS by computational analysis.  
Aim We extended our previous work by analyzing the expression of miR-21, miR-34a and three other 
highly ranked miRNAs (miR-145, miR-146b-5p and miR-381) in BOS and other lung diseases 
associated with fibroblast activation/proliferation and collagen deposition. Identifying a specific 
profile of dysregulated miRNAs could provide useful diagnostic markers and potential therapeutic 
target. 
Methods We evaluated miRNAs expression profile by ISH and RT-PCR quantification in a series of 
formalin-fixed and paraffin-embedded lung samples obtained from patients with IPF (n. 8), OP (n. 
8), BOS (n. 12) and normal lung from organ donors. 	
Results In BOS, COP and IPF/UIP miR-21 and miR-145 were expressed in fibroblasts of BO lesions, 
OP plugs and in fibroblast foci respectively, and in reactive alveolar epithelia; miR-146b expression 
correlated to the amount of inflammatory cell infiltrates and epithelial activation in all cases, while a 
weak expression was evident in OP and IPF/UIP lesions. miR-34a overexpression was associated 
with the activation of alveolar epithelia and to a lesser extent with fibroblast lesions in OP. miR-381 
showed a weak expression in all diseases, and was localized especially in inflammatory cells. ISH 
data have been confirmed by qRTPCR analysis obtained on same samples. 	
Conclusions miR-21, miR-145 and miR-146b are over-expressed in fibroblasts in all the cases 
analyzed, but their expression is not disease-specific, although some differences are observed in 
different diseases. This finding underlies their role in non-specific fibrotic lung processes.ISH 
complements the results of qPCR, allows the precise cellular localization of miR expression, and 
improves correlations with cell-specific pathways 
